AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹7,094 Cr | ₹5,746 Cr | ₹4,817 Cr | ₹4,466 Cr | ₹4,012 Cr |
What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹7,094 Cr |
| Mar2025 | ₹5,746 Cr |
| Mar2024 | ₹4,817 Cr |
| Mar2023 | ₹4,466 Cr |
| Mar2022 | ₹4,012 Cr |
How is Sundry Debtors of AUROBINDO PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,094 Cr | 23.47 | |
| Mar2025 | ₹5,746 Cr | 19.29 | |
| Mar2024 | ₹4,817 Cr | 7.84 | |
| Mar2023 | ₹4,466 Cr | 11.32 | |
| Mar2022 | ₹4,012 Cr | - | |
Compare Sundry Debtors of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹99,256.5 Cr | 2.4% | 7.2% | 54.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,476.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,764.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,423.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,005.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 2.4% |
7.2% |
54.8% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses